Rigel Pharma (RIGL) Tops Q3 EPS by 1c

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.93 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
• NXP Semiconductors names Mike Lucarelli as new investor relations head